The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: A Turkish oncology group kidney cancer consortium (TKCC) study için istatistikler

Toplam ziyaret

views
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: A Turkish oncology group kidney cancer consortium (TKCC) study 0

Aylık toplam ziyaret

views
Ekim 2024 0
Kasım 2024 0
Aralık 2024 0
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0